Correlation Between Lyra Therapeutics and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Recursion Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and Recursion Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Lyra and Recursion is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Recursion Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Recursion Pharmaceuticals. In addition to that, Lyra Therapeutics is 1.11 times more volatile than Recursion Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest 717.00 in Recursion Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 7.00 from holding Recursion Pharmaceuticals or generate 0.98% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Lyra Therapeutics vs. Recursion Pharmaceuticals
Performance |
Timeline |
Lyra Therapeutics |
Recursion Pharmaceuticals |
Lyra Therapeutics and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lyra Therapeutics and Recursion Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.Lyra Therapeutics vs. Fate Therapeutics | Lyra Therapeutics vs. Caribou Biosciences | Lyra Therapeutics vs. Karyopharm Therapeutics | Lyra Therapeutics vs. Hookipa Pharma |
Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |